A research team from the Korea Advanced Institute of Science and Technology (KAIST)<\/b> has developed an innovative system that ensures high-precision modeling of physiological interactions between organs. The platform allows for a detailed study of the mechanisms underlying the development of rhabdomyolysis<\/b>. Rhabdomyolysis is the destruction of muscle tissue that can be caused by various etiological factors: pharmacological effects, extreme physical exertion (such as marathon running), or mechanical trauma (muscle tissue compression).<\/p>\n
During this process, the muscle structural protein myoglobin<\/b> is released into the bloodstream. Although it is a natural substance for the body, excessive concentrations are nephrotoxic<\/b> and lead to acute kidney failure. Until now, monitoring the direct impact of muscle degradation products on the kidneys in real-time has been a significant challenge for the scientific community.<\/p>\nTechnical Design and Functionality<\/b><\/h4>\n
The new technology is a modular, assembly-based microfluidic chip. Its primary advantage lies in the fact that organ tissues are functionally connected, yet can be easily separated when necessary. Based on 3D engineering, the small chip houses 3D-modeled muscle tissue and proximal tubule epithelial cells, which are crucial for renal function.<\/p>\n
The system’s flexibility allows muscle and kidney tissues to be grown independently in their respective optimal environments. They are connected only during the actual experiment to facilitate organ-to-organ interaction. The accuracy of the analysis is further enhanced by the ability to decouple the tissues after the experiment, enabling scientists to independently and quantitatively evaluate changes in each organ with maximum precision.<\/p>\n
Researchers tested the system\u2019s efficacy on widely used pharmacological agents such as Atorvastatin<\/b> (a lipid-lowering medication used to regulate cholesterol) and Fenofibrate<\/b>. It is noteworthy that statins represent the gold standard for cardiovascular disease prevention in modern medicine, and the risk of muscular complications in clinical practice is extremely low.<\/p>\n
Nevertheless, to study negative effects observed in rare cases, this biochip provided scientists with an unprecedented opportunity to observe the molecular mechanisms underlying muscle tissue damage in detail. This technology enables the laboratory simulation of rare scenarios that were previously difficult to predict using traditional methods.<\/p>\n
Tests conducted on the chip revealed significant changes at the muscular level: muscle contractile force decreased, structural integrity was compromised, and the release of damage markers such as myoglobin<\/b> and CK-MM<\/b> increased sharply. Simultaneously, at the renal level, it was found that toxic substances released from the muscle caused cell death. Furthermore, a sharp increase in specific injury biomarkers, NGAL<\/b> and KIM-1<\/b>, was recorded, indicating acute kidney failure.<\/p>\nSignificance of the Achievement<\/b><\/h4>\n
This study, published in the journal Advanced Functional Materials<\/i><\/b>, lays the groundwork for predicting drug side effects at an early stage. According to the scientists, this platform will assist in the development of personalized medicine and a deeper understanding of the causes of acute kidney injury, ultimately minimizing life-threatening risks.<\/p>\n